Gadolinium
- Generic Name
- Gadolinium
- Drug Type
- Small Molecule
- Chemical Formula
- Gd
- CAS Number
- 7440-54-2
- Unique Ingredient Identifier
- AU0V1LM3JT
Overview
Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease.
Background
Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
MetDetox
Manufacturer:Dr. Donna Restivo DC
Route:ORAL
Strength:12 [hp_X] in 1 mL
Approved: 2025/05/23
NDC:62185-0062
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath